Metropolis Healthcare is a diagnostics company, with presence in 23 states & 601 towns. Internationally, the company has presence in South Asia, Africa, and the Middle East. It offers a comprehensive range of 4,000 plus tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. The company has a network of over 199 labs, 4,150 collection centres and over 10,000 touch points.
The company’s consolidated net profit jumped 31.8% to Rs 37.95 crore on 13.1% rise in revenue from operations to Rs 313.36 crore in Q1 FY25 over Q1 FY24.
The scrip rose 0.70% to settle at Rs 2,273.05 on Friday, 11 October 2024.